Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multi-target CAR-T for Advanced Lung Cancer
NCT03198052Phase 1Recruiting
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Start
- Jul 2017
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in lung cancer and solid tumor (advanced stage), sponsored by Second Affiliated Hospital of Guangzhou Medical University. Primary endpoint: Dose Limiting Toxicity at 3 months. Started Jul 2017; status: recruiting.
02
Conditions
lung cancersolid tumor (advanced stage)
Beyond the preview
Go deeper on NCT03198052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03198052.